Clinical Trial: Echinocandin Added to Standard Treatment for Severe Pneumocystis Pneumonia

U.S., Oct. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07900373) titled 'Echinocandin Added to Standard Treatment for Severe Pneumocystis Pneumonia' on Oct. 21.

Brief Summary: Preclinical studies and retrospective clinical data suggest that adjunctive echinocandin therapy may improve outcomes in adults with severe Pneumocystis jirovecii pneumonia (PCP). However, the benefit of adding an echinocandin to standard PCP treatment has not been established in a definitive randomized controlled trial. The aim of this trial is:

1. In adults hospitalized with severe PCP, to determine whether adding an echinocandin to standard anti-PCP therapy improves net clinical outcomes by Day 30 compared with standard anti-PC...